Norway· NO-ID_F0514018-BF45-4AF1-A7B1-F0D2052BB490
NovoSeven
A coagulation factor viia product containing eptacog alfa (activated), registered in Norway by Novo Nordisk A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Coagulation factor viia is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD08 (coagulation factor viia), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Coagulation factor viia · ATC B02BD08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Eptacog Alfa (Activated)
- Manufacturer
- Novo Nordisk A/S
- Country
- Norway (NO)
- ATC code
- B02BD08
- ATC class
- Coagulation factor VIIa
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_F0514018-BF45-4AF1-A7B1-F0D2052BB490
- no_varenummer4143311NOK 30097
- gtin5712249102869
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for coagulation factor viia.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor viia · interactions on record
5 records
- 2 severe
- 2 moderate
- 1 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03moderate
- EmicizumabB02BX06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor viia in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCevenfacta 5mg (225,000units) powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- BelgiumCevenfacta 5 mgLaboratoire français du Fractionnement et des Biotechnologies
- SpainNOVOSEVEN 5 mg (250 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- SwedenCEVENFACTA 5 mg Pulver och vätska till injektionsvätska, lösningLaboratoire français du Fractionnement et des Biotechnologies
- IrelandCEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLaboratoire francais du Fractionnement et des Biotechnolgies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
- FinlandNovosevenNovo Nordisk A/S
- SwitzerlandNovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Cevenfacta, Novoseven
- Liechtenstein · Cevenfacta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f39acb88-695a-45f8-86f7-dda00d3c4006 GET /v1/drugs/f39acb88-695a-45f8-86f7-dda00d3c4006?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Koagulasjonsfaktor VIIa",
"merkevare_id": "ID_F0514018-BF45-4AF1-A7B1-F0D2052BB490",
"name_form_strength": "NovoSeven pulv+væske til inj oppl 5 mg/sprøyte",
"prescription_group": "C"
}See everything about coagulation factor viia.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.